0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Targeted and Immune Cancer Therapy

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
Related JAMA Psychiatry Collections
From The JAMA Network
JAMA Oncology
Brief Report  | 
Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors
Aaron P. Mitchell, MD; Ethan M. Basch, MD, MSCr; Stacie B. Dusetzina, PhD
JAMA Oncology
Research Letter  | 
Capecitabine and the Risk of Fingerprint Loss
Leni van Doorn, MSc; Sebastiaan Veelenturf, MSc; Lisette Binkhorst, PharmD, PhD; et al.
JAMA Oncology
Original Investigation  | 
Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered A Post hoc Analysis of the Mainsail Study
Ellen S. de Morrée, MSc; Nicholas J. Vogelzang, MD; Daniel P. Petrylak, MD; et al.
JAMA Oncology
Review  | 
The Role of Genetic Testing in the Selection of Therapy for Breast Cancer A Review
Polly Niravath, MD; Burcu Cakar, MD; Matthew Ellis, MB, BChir, PhD, FRCP